LUXCHEM CORPORATION

LUXCHEM
End-of-day quote. End-of-day quote  - 11/23
0.82MYR -0.61%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 765734
EBITDA1 58,165,0
Operating profit (EBIT)1 54,761,0
Operating Margin 7,15%8,31%
Pre-Tax Profit (EBT)1 50,157,0
Net income1 37,643,0
Net margin 4,92%5,86%
EPS2 0,040,05
Dividend per Share2 0,020,02
Last update 02/17/202010/28/2020
1 MYR in Million
2 MYR
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow --
ROE (Net Profit / Equities) 12,7%13,4%
Shareholders' equity1 296321
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share2 0,340,37
Cash Flow per Share --
Capex1 7,219,35
Capex / Sales 0,94%1,27%
Last update 02/17/202010/28/2020
1 MYR in Million
2 MYR
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 735 M MYR -
Valuation 2020e 2021e
P/E ratio (Price / EPS) 16,4x 16,4x
Capitalization / Revenue 1,00x 0,92x
Yield (DPS / Price) 2,62% 3,23%
Price to book (Price / BVPS) 2,22x 2,10x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 8,31% 8,62%
Operating Leverage (Delta EBIT / Delta Sales) - 1,46x
Net Margin (Net Profit / Revenue) 5,86% 6,00%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 13,4% 14,2%
Rate of Dividend 43,0% 53,0%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   1,27% 1,17%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend